Introduction: Aloe barbadensis (L.) Miller (Aloe vera) is a widely used ethnomedicinal plant applied for burns, wounds, digestive ailments, and skin disorders. Its therapeutic effects are attributed to bioactive compounds such as anthraquinones, polysaccharides, flavonoids, chromones, vitamins, and minerals. This review critically summarizes recent advances (2018-2025) in the ethnopharmacology, phytochemistry, and pharmacological activities of A. barbadensis. Methods: Relevant literature was retrieved from databases, including PubMed, ScienceDirect, Springer, NCBI, and Google Scholar, with a focus on preclinical and clinical studies. Results: Preclinical evidence demonstrates antimicrobial, anti-inflammatory, antioxidant, anticancer, and wound-healing properties, largely driven by synergistic phytoconstituents. Additional benefits include immune modulation, oxidative stress reduction, and gastrointestinal protection. Clinical studies remain limited, primarily evaluating crude extracts for dermatological and digestive applications. The lack of robust randomized trials and compound-specific investigations limits clinical translation. Discussion: A. barbadensis shows promise as a multi-target therapeutic agent, particularly in inflammation, oxidative stress, and skin health. However, variability in phytochemical composition and insufficient standardization hinder its broader application. Conclusion: While supported by traditional use and preclinical findings, its clinical potential requires validation through well-designed trials, mechanistic studies, and standardized formulations.